NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/28/2024
Back to search
Official data from USPTO
PROSTATE CANCER FOUNDATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROSTATE CANCER FOUNDATION
ST13
US500000076462461Class
36
Filing
76462461
Registration
2875765
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/28/2024
Trademark type
Word
Nice classes
36
Filing date
10/23/2002
Registration date
08/17/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2024
Last transaction
03/28/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2003-04-00
First use in commerce
2003-04-00
Drawing code
1
Owner type
03
Owner location
Santa Monica, CA, US
Examiner
MADDEN, ANNE
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
P. F. (pessoa física)
P. F. (pessoa física)
Association for the Cure of Cancer of the Prostate
Representatives
Jessica Bromall Sparkman JEFFER MANGELS BUTLER & MITCHELL LLP
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable servicesraising funds and making grants to increase public awareness of prostate cancer and to support research and activities relating to the treatmentprevention and cure of prostate cancer
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/28/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/28/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/28/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
11/03/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/17/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/30/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/30/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/30/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/30/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
08/13/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/11/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/02/2010
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
08/20/2010
PAPER RECEIVED
08/20/2010
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
08/17/2004
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
06/10/2004
XAEC
EXAMINER'S AMENDMENT ENTERED
06/04/2004
CNEA
EXAMINERS AMENDMENT MAILED
06/04/2004
IUAA
USE AMENDMENT ACCEPTED
06/02/2004
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/02/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2003
PAPER RECEIVED
11/06/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2003
IUAF
USE AMENDMENT FILED
11/03/2003
CNRT
NON-FINAL ACTION MAILED
05/02/2003
DOCK
ASSIGNED TO EXAMINER
03/14/2003
Continuous trademark protection
Get notified about every new filing that threatens PROSTATE CANCER FOUNDATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.